Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-15-012683)

Filing Details

Accession Number:: 0001179110-15-012683
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-26 19:54:07
Reporting Period:: 2015-08-24

Filing Date:: 2015-08-26
Accepted Time:: 2015-08-26 19:54:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323113	Jr N Daniel Swisher	C/O Sunesis Pharmaceuticals, Inc. 395 Oyster Point Blvd., Ste. 400 South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-24	12,784	$1.01	187,520	No	4	P	Indirect	See footnote.
Common Stock	Acquisiton	2015-08-25	12,216	$1.01	199,736	No	4	P	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote.
No	4	P	Indirect	See footnote.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	179,510	Direct

Footnotes

Because of a typographical error, the amount of securities beneficially owned indirectly by the reporting person was incorrectly reported as 174,336 shares instead of 174,736 shares in the last Form 4 filing. The total amount of the reporting person's indirect holdings on this report incorporates this correction.
The shares are held by the Swisher Revocable Trust for which reporting person is a Trustee.